October 30, 2024 10:31 AM EDT

Leal Therapeutics raises $45M; SynOx adds to Series B

ENDPOINTS

Plus, news about Zai Lab, Spero Therapeutics and EyePoint Pharmaceuticals:

Leal Therapeutics raises $45M: The biotech, which emerged from stealth earlier this …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Exclusive: Kennedy picks for vaccine advisory board were paid experts against Merck in civil cases

Kennedy's vaccine doubts hinge on 'inert' placebos, but experts say he misunderstands the science

CureVac CEO on BioNTech deal: Come together 'rather than fighting each other in court'

Insmed aims to raise $750M in one of the largest stock offerings this year

RFK Jr. names eight new ACIP members, including popular vaccine critic Robert Malone

sponsored

McKesson leads the charge in revolutionizing precision oncology in community practices